Drug · DIN 00465283
HYDREA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since November 18, 2022; first marketed December 31, 1979.
- Drug Identification Number (DIN)
- 00465283
- Company (DIN owner)
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Hydroxycarbamide L01XX05
- Class
- Human
- Record last updated
- July 27, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HYDROXYUREA | 500 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 8, 2022: NOC 29415New Drug Submission (NDS) · Administrative: Change in Product Ownership
- October 28, 2004: NOC 5727New Drug Submission (NDS) · Manufacturer name change
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “hydrea”. A notice may cover another product or only some lots: read it to see what it covers.